As expected, DPAICP@ME played its predetermined role in vivo through oral administration to restore p53 signaling pathway for cancer therapy in B16F10 homograft malignant melanoma model, LLC Lewis in situ model of lung cancer and patient-derived orthotopic xenograft (PDOX) mice model of colon carcinoma. The gene discussed is TP53; the disease is lung cancer.